Following CE Mark approval Quantum Surgical announces the commercial launch of Epione® its medical robot dedicated to liver cancer
Montpellier, France, September 7, 2021 - Quantum Surgical, an innovative medical robot-ics company, announces that it has recently obtained CE mark approval for Epione®, its robot designed for minimally invasive treatment of abdominal tumors. This authorization allows the commercial launch of Epione® on the European market.
Epione® is a robotic solution developed to help physicians perform safer and more effec-tive percutaneous ablations in the abdomen, a minimally invasive treatment in which a needle is inserted through the skin to the tumor to remove it. Epione® ensures reliability and accuracy, two key factors to improve current practice and reduce variability. Epione®, assists practitioners in managing patients, from preoperative planning to the end of the procedure.
The CE mark follows the successful treatment of 21 patients with the Epione® robot in a multi-center clinical study completed earlier this year.
"This is a major milestone for Quantum Surgical, as the CE mark approval is the starting point towards the commercialization of the robot. This clearance will allow many more patients to benefit from Epione® as there is a significant need for minimally invasive ther-apies in cancer treatment," declares Bertin NAHUM, CEO, and co-founder of Quantum Sur-gical.
Webinar on Robotics in Image Guided Ablation
Discover the power of Robotics in Image Guided Ablation during our upcoming webinar, featuring a live Q&A. Get your questions answered by experts from around the world. Don't miss this insightful session brought to you by Spectrum Cancer and Quantum Surgical.
Topics include:
- Benefits and challenges of robotics during ablation procedures
- Learning curves
- How to approach administration about adopting robotics
- Case presentations
- And live Q&A
Join us for this virtual event with live Q&A.
Limited spots.
REGISTER NOW!
CIRSE 2025, September 13-17
Organized by the Cardiovascular and Interventional Radiology Society of Europe, the CIRSE 2025 event is the world's biggest meeting focusing on interventional radiology and will take place in Barcelona, Spain from September 13-17, 2025.
For 40 years, the CIRSE annual congress has provided the world’s premier platform for specialists in minimally invasive image-guided procedures to meet, share and connect. Quantum Surgical is delighted to announce its renewed participation this year, underscoring our commitment to advancing medical innovation and collaboration within this dynamic community.
Explore Epione®, our unique robotic-assisted platform empowering physicians to Plan, Target, Deliver, and Confirm tumor ablation.
Visit us at Quantum Surgical Booth.
You can already set-up a meeting with out team for a personalized Epione® demo. Request a demo – Quantum Surgical or email us at info@quantumsurgical.com
Event Details:
- Date: September 13-17, 2025
- Location: Centre de Convencions International de Barcelona, Spain
CIO 2025, October 17-19, 2025
CIO 2025 will be held in Miami, Florida, October 17 to 19.
The Symposium on Clinical Interventional Oncology (CIO) is the ultimate destination for clinicians passionate about advancing cancer through interventional oncology (IO).
Designed for practicioners at every stage of their IO journey, CIO delivers a comprehensive curriculum that spans foundational techniques to the latest innovations in robotics, systemic treatments, and emerging therapies.
Spend a weekend with experts in Miami and learn how the EPIONE® robotic platform will impact your clinical practice.
If you would like a more personalized demo, contact us at info@quantumsurgical.com and let the Quantum Surgical Team introduce you to EPIONE®, the all-in-one robotic platform designed to plan, target, deliver and confirm percutaneous ablation procedures..
We look forward to seeing you in Miami!
Event Details
Date :
- October 17-19, 2025
Location :
- Loews Miami Beach, Florida